Jennewein and Chr Hansen joins forces in high-growth human milk oligosaccharides market
Jennewein Biotechnologie announces the foundation of Jennewein Biotech Corp. USA
Jennewein publishes new results on the norovirus-inhibiting effect of complex oligosaccharides
Positive outlook for 5’-HMO growth and tolerance trial in infants
Human milk oligosaccharides promote a healthy gut microbiota in infants
Jennewein Biotechnologie acquires Arthus Mineralsprings
Clinical trial emulating the human profile of infant formula
